CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-10 | Cooke Shane Director | Sale | −2,324 | $55.37 | $129K | 2,676 |
| 2022-10-10 | Cooke Shane Director | Sale | −2,676 | $56.38 | $151K | 0 |
| 2022-10-10 | Cooke Shane Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 15,000 | ||
| 2022-10-05 | COLLIER RICHARD T Director | Option exercise | +5,000 | $6.41 | $32K | 6,219 |
| 2022-10-05 | COLLIER RICHARD T Director | Sale | −890 | $56.54 | $50K | 5,329 |
| 2022-10-05 | COLLIER RICHARD T Director | Sale | −3,404 | $57.97 | $197K | 1,925 |
| 2022-10-05 | COLLIER RICHARD T Director | Sale | −352 | $58.94 | $21K | 1,573 |
| 2022-10-05 | COLLIER RICHARD T Director | Sale | −354 | $59.95 | $21K | 1,219 |
| 2022-10-05 | COLLIER RICHARD T Director | Option exercise · Stock Option (Right to Buy) | +5,000 | 15,000 | ||
| 2022-10-03 | Garren Hideki Chief Medical Officer | Option exercise | +4,000 | $24.90 | $100K | 4,000 |
| 2022-10-03 | Garren Hideki Chief Medical Officer | Sale | −4,000 | $60.90 | $244K | 0 |
| 2022-10-03 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,000 | 230,000 | ||
| 2022-10-03 | Ekman Lars Director | Option exercise | +15,833 | $6.41 | $101K | 16,076 |
| 2022-10-03 | Ekman Lars Director | Sale | −3,508 | $60.32 | $212K | 12,568 |
| 2022-10-03 | Ekman Lars Director | Sale | −4,277 | $61.07 | $261K | 8,291 |
| 2022-10-03 | Ekman Lars Director | Sale | −6,355 | $62.11 | $395K | 1,936 |
| 2022-10-03 | Ekman Lars Director | Sale | −1,693 | $62.96 | $107K | 243 |
| 2022-10-03 | Ekman Lars Director | Option exercise · Stock Option (right to buy) | −15,833 | 47,501 | ||
| 2022-09-28 | Kinney Gene G. President and CEO | Option exercise | +16,412 | $6.41 | $105K | 29,205 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −1,045 | $48.09 | $50K | 28,160 |
Page 23 of 28 · 555 trades